Free Trial
OTCMKTS:BAYRY

Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis

$8.01
-0.04 (-0.50%)
(As of 09/6/2024 ET)
Today's Range
$8.00
$8.12
50-Day Range
$6.83
$8.06
52-Week Range
$6.82
$13.82
Volume
423,634 shs
Average Volume
1.50 million shs
Market Capitalization
$31.48 billion
P/E Ratio
N/A
Dividend Yield
0.25%
Price Target
N/A
BAYRY stock logo

About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

BAYRY Stock Price History

BAYRY Stock News Headlines

What is Nvidia’s New $1 Trillion SuperProject?
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …
Three Bayer Leverkusen players nominated for the Ballon d’Or
UBS Remains a Hold on Bayer (0P6S)
Bayer (0P6S) Receives a Hold from J.P. Morgan
What is Nvidia’s New $1 Trillion SuperProject?
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …
PLAYER RATINGS | Bayer Leverkusen 2-3 RB Leipzig
See More Headlines
Receive BAYRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/06/2024
Today
9/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:BAYRY
Employees
99,723
Year Founded
1863

Profitability

Net Income
$-3,183,040,000.00
Pretax Margin
-3.37%

Debt

Sales & Book Value

Annual Sales
$51.55 billion
Cash Flow
$3.99 per share
Book Value
$10.44 per share

Miscellaneous

Outstanding Shares
3,929,700,000
Free Float
N/A
Market Cap
$31.48 billion
Optionable
Not Optionable
Beta
1.04

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. William N. Anderson (Age 58)
    Chairman of the Management Board & CEO
    Comp: $9.16M
  • Mr. Wolfgang U. Nickl (Age 55)
    CFO & Member of Management Board
    Comp: $2.15M
  • Mr. Heiko W. J. Schipper (Age 55)
    Member of Management Board & President of the Consumer Health Division
    Comp: $2.11M
  • Mr. Stefan Oelrich (Age 56)
    Head of the Pharmaceuticals Division & Member of the Board of Management
    Comp: $2.11M
  • Mr. Rodrigo Santos (Age 51)
    Member of Management Board & President of the Crop Science Division
    Comp: $2.35M
  • Ms. Heike Prinz (Age 60)
    Chief Talent Officer, Labor Director & Member of Management Board
    Comp: $1.44M
  • Mr. Julio Triana (Age 58)
    Member of Management Board & President of Consumer Health Division
  • Dr. Sebastian Guth Ph.D.
    Chief Operating Officer
  • Dr. Jost Reinhard (Age 52)
    Head of Investor Relations
  • Mr. Michael Preuss
    Head of Communications, Government Relations and Corporate Brand

BAYRY Stock Analysis - Frequently Asked Questions

How have BAYRY shares performed this year?

Bayer Aktiengesellschaft's stock was trading at $9.23 on January 1st, 2024. Since then, BAYRY shares have decreased by 13.2% and is now trading at $8.0101.
View the best growth stocks for 2024 here
.

How were Bayer Aktiengesellschaft's earnings last quarter?

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) issued its quarterly earnings results on Tuesday, August, 6th. The company reported $0.25 EPS for the quarter, meeting analysts' consensus estimates of $0.25. The company had revenue of $12 billion for the quarter. Bayer Aktiengesellschaft had a negative net margin of 2.74% and a positive trailing twelve-month return on equity of 16.96%.

Does Bayer Aktiengesellschaft have any subsidiaries?

Bayer Aktiengesellschaft subsidiaries include these companies: Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and more.

How do I buy shares of Bayer Aktiengesellschaft?

Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BAYRY) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners